These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25583643)

  • 1. Apolipoprotein E levels and Alzheimer risk.
    Hyman BT; Holtzman DM
    Ann Neurol; 2015 Feb; 77(2):204-5. PubMed ID: 25583643
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels of apolipoprotein E and risk of dementia in the general population.
    Rasmussen KL; Tybjaerg-Hansen A; Nordestgaard BG; Frikke-Schmidt R
    Ann Neurol; 2015 Feb; 77(2):301-11. PubMed ID: 25469919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review.
    Rasmussen KL
    Atherosclerosis; 2016 Dec; 255():145-155. PubMed ID: 28340945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E-epsilon 4 frequency in geriatric depression.
    Krishnan KR; Tupler LA; Ritchie JC; McDonald WM; Knight DL; Nemeroff CB; Carroll BJ
    Biol Psychiatry; 1996 Jul; 40(1):69-71. PubMed ID: 8780857
    [No Abstract]   [Full Text] [Related]  

  • 5. Apolipoprotein E genotype and lipid and lipoprotein levels in dementia.
    Wehr H; Parnowski T; Puzyński S; Bednarska-Makaruk M; Bisko M; Kotapka-Minc S; Rodo M; Wołkowska M
    Dement Geriatr Cogn Disord; 2000; 11(2):70-3. PubMed ID: 10705163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients.
    Bednarska-Makaruk M; Rodo M; Graban A; Lojkowska W; Bochyńska A; Ryglewicz D; Wehr H
    J Neurol Sci; 2009 Aug; 283(1-2):137-8. PubMed ID: 19303604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality in dementia.
    Guehne U; Riedel-Heller S; Angermeyer MC
    Neuroepidemiology; 2005; 25(3):153-62. PubMed ID: 15990446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased levels of serum nitric oxide in different forms of dementia.
    Corzo L; Zas R; Rodríguez S; Fernández-Novoa L; Cacabelos R
    Neurosci Lett; 2007 Jun; 420(3):263-7. PubMed ID: 17556102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of apolipoproteins E genotyping in the differential diagnosis of dementia].
    Slooter AJ; van Gool WA; van Duijn CM
    Ned Tijdschr Geneeskd; 1996 Oct; 140(42):2073-6. PubMed ID: 8965948
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum apolipoprotein A I, B100 and E levels and apolipoprotein E polymorphism in patients with Alzheimer's disease and multiple infarction dementia in Chinese population].
    Fan P; Liu Y; Zhang Z; Liu B; Ge W; Ye S; Cheng Y; Chen J
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):389-91. PubMed ID: 12536572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apolipoprotein E genotypes in patients investigated for dementia].
    Johannsen P; Jakobsen JK; Jørgensen AL
    Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum apolipoprotein E is associated with long-term risk of Alzheimer's disease: The Rotterdam Study.
    Wolters FJ; Koudstaal PJ; Hofman A; van Duijn CM; Ikram MA
    Neurosci Lett; 2016 Mar; 617():139-42. PubMed ID: 26876448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E as vascular risk factor in neurodegenerative dementia.
    Folin M; Baiguera S; Conconi MT; Di Liddo R; De Carlo E; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2004 Oct; 14(4):609-13. PubMed ID: 15375590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apolipoprotein-E4, lipid profile and vascular dementia].
    Spada RS; Ferri R; Mangiafico RA; Roccasalva G; Toscano G
    Minerva Cardioangiol; 1999 Dec; 47(12):522-3. PubMed ID: 10670184
    [No Abstract]   [Full Text] [Related]  

  • 15. Apolipoprotein E genotyping in Alzheimer's disease.
    McKeith IG; Morris CM
    Lancet; 1996 Jun; 347(9017):1775. PubMed ID: 8656943
    [No Abstract]   [Full Text] [Related]  

  • 16. Onset of dementia is associated with apolipoprotein E epsilon4 in Down's syndrome.
    Schupf N; Kapell D; Lee JH; Zigman W; Canto B; Tycko B; Mayeux R
    Ann Neurol; 1996 Nov; 40(5):799-801. PubMed ID: 8957023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of clinical and neuropsychologic information as a better predictor of the progression to Alzheimer disease in questionable dementia individuals.
    Lee DY; Youn JC; Choo IH; Kim KW; Jhoo JH; Pak YS; Suh KW; Woo JI
    Am J Geriatr Psychiatry; 2006 Feb; 14(2):130-8. PubMed ID: 16473977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+.
    Forsell Y; Corder EH; Basun H; Lannfelt L; Viitanen M; Winblad B
    Biol Psychiatry; 1997 Nov; 42(10):898-903. PubMed ID: 9359975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia among elderly apolipoprotein E type 4/4 homozygotes: a prospective study.
    Ganguli M; Cauley JA; DeKosky ST; Kamboh MI
    Genet Epidemiol; 1995; 12(3):309-11. PubMed ID: 7557352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
    Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
    Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.